COMPREHENSIVE
DEVICE FOLLOW-UP
EDUCATION
You just clicked a link to go to another website. If you continue, you may go to a site run by someone else.
We do not review or control the content on non-Medtronic sites, and we are not responsible for any business dealings or transactions you have there. Your use of the other site is subject to the terms of use and privacy statement on that site.
It is possible that some of the products on the other site are not approved in your region or country.
Your browser is out of date
With an updated browser, you will have a better Medtronic website experience. Update my browser now.
The content of this website is exclusively reserved for Healthcare Professionals in countries with applicable health authority product registrations, except those practicing in France as some of the content is not in compliance with the French Advertising law N°2011-2012 dated 29th December 2011, article 34.
Click “OK” to confirm you are a Healthcare Professional.
At Medtronic, we understand that innovation is not driven by ourselves alone. We believe in working with you to apply the full power of technology for better patient outcomes. We do this by collaborating on meaningful innovation with you to create the most advanced and disruptive technologies and best-in-class therapies for your patients.
MIT Technology Review Insights examines how smart medical technology is revolutionizing medicine and the future of personalized patient care.
VIEW PAPERInnovation doesn’t end at implant.
LEARN MOREUsing Modeling Study of 20 different patient anatomies, selected to include patients with atria ranging from 38-197 mL RA volumes. Across tested anatomies, the C304-HIS improved fixation success rate vs C315HIS in larger RAs with volumes between 110 mL and 139 mL (vs. C315).
Gierula J, Paton MF, Witte KK. Advances in cardiac resynchronization and implantable cardioverter/defibrillator therapy: Medtronic Cobalt and Crome. Future Cardiol. 2021 Jul;17(4):609-618.
Ousdigian KT, Rosemas S, Koehler JL, Cheng YJ, Kloosterman EM. New Algorithms and Tailored Programming of Insertable Cardiac Monitors Reduce Alerts and Time Required to Follow Patients. Circulation 142(Suppl 3): 16568.
Van Heel L, et al. Circulation. 2019;140:A11830
2020 MedTech Breakthrough Award Winners - Best Overall Connected Healthcare Solution: Medtronic, MyCareLink™ Heart mobile app: https://hitconsultant.net/2020/05/21/2020-medtech-breakthrough-award-winners/#.YJ1jD6gzZPY
Seiler A, et al. Clinic time required for remote and in-person management of cardiac device patients: Time and motion workflow evaluation. JMIR Cardio (Forthcoming). doi:10.2196/27720
Steinwender C, Khelae SK, Garweg C, et al. Atrioventricular synchronous pacing using a leadless ventricular pacemaker: Results from the MARVEL 2 study. JACC Clin Electrophysiol. Published online November 2, 2019.
Massdevice, Medtronic lands CE Mark for Micra AV transcatheter pacing system, June 15, 2020, https://www.massdevice.com/medtronic-micra-av-lands-ce-mark/
Auricchio A, et al. Heart Rhythm. 2015;12:926-936.
Swenson DJ, et al. A Direct Comparison of a Novel Antitachycardia Pacing Algorithm Against Present Methods Using Virtual Patient Modeling, Heart Rhythm (2020)
BRIEF STATEMENT
See the device manual for detailed information regarding the instructions for use, the implant procedure, indications, contraindications, warnings, precautions, and potential adverse events. If using an MRI SureScan™ device, see the MRI SureScan™ technical manual before performing an MRI. For further information, contact your local Medtronic representative and/or consult the Medtronic website at medtronic.eu.
For applicable products, consult instructions for use on www.medtronic.com/manuals. Manuals can be viewed using a current version of any major internet browser. For best results, use Adobe Acrobat® Reader with the browser.
Important Reminder: This information is intended only for users in markets where Medtronic products and therapies are approved or available for use as indicated within the respective product manuals. Content on specific Medtronic products and therapies is not intended for users in markets that do not have authorization for use.